Newstral
Article
Mmarketwatch.com on 2021-10-28 20:29
Merck's COVID-19 pill could bring in $7 billion in sales next year3 min read
Related news
- BWall Street Cheered Merck's Covid Pill. Some Scientists Are Highlighting Its Potential Dangers.7 min readbarrons.com
- MAfter high hopes for Merck's COVID-19 pill, Wall Street now expects a 'tepid' authorization3 min readmarketwatch.com
- MFDA advisers to vote Tuesday on Merck's COVID-19 pill even as interest has waned3 min readmarketwatch.com
- BPfizer Says It Will Now Sell $33.5 Billion of Its Covid-19 Vaccine This Year3 min readbarrons.com
- BMerck's Covid Pill Gets an FDA Hearing Today. What's at Stake. 5 min readbarrons.com
- MWhat Merck's antiviral pill could mean for vaccine hesitancy --- 'It's not a magic pill'4 min readmarketwatch.com
- MSalesforce stock soars after earnings beat, forecast that calls for more profit this year3 min readmarketwatch.com
- MThis junk-bond-market measure signals appetite for risk as stocks jump this year3 min readmarketwatch.com
- BMerck's Earnings Guidance for 2022 Misses Estimates. The Stock Dips.1 min readbarrons.com
Merck's Covid-19 pill may not be a game-changerCNN
- MWhy the U.S. might have lost jobs for the first time in more than a year3 min readmarketwatch.com
FDA Approves Merck's Antiviral Pill For Emergency UseForbes
Malaysia buys 150,000 courses of Merck's COVID-19 pillThe Jerusalem Post (JPost.com)
Merck's COVID-19 treatment pill lands in IsraelThe Jerusalem Post (JPost.com)
ECU joins clinical trial for Merck's Covid-19 pillbizjournals.com
FDA authorizes Merck's at-home antiviral coronavirus pillThe Toledo Blade
UK authorizes Merck's COVID pill, 1st shown to treat COVIDKING 5
Merck's COVID-19 pill effective against Omicron in lab studiesThe Jerusalem Post (JPost.com)
Panel weighs safety, effectiveness of Merck's covid-19 pillArkansas Online
Merck's Covid Treatment Pill: What to Know About MolnupiravirThe New York Times